<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38257728</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>24</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Dec</Month><Day>23</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>The Functional Roles of MDSCs in Severe COVID-19 Pathogenesis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">27</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v16010027</ELocationID><Abstract><AbstractText>Severe COVID-19 is a major cause of morbidity and mortality worldwide, especially among those with co-morbidities, the elderly, and the immunocompromised. However, the molecular determinants critical for severe COVID-19 progression remain to be fully elucidated. Meta-analyses of transcriptomic RNAseq and single-cell sequencing datasets comparing severe and mild COVID-19 patients have demonstrated that the early expansion of myeloid-derived suppressor cells (MDSCs) could be a key feature of severe COVID-19 progression. Besides serving as potential early prognostic biomarkers for severe COVID-19 progression, several studies have also indicated the functional roles of MDSCs in severe COVID-19 pathogenesis and possibly even long COVID. Given the potential links between MDSCs and severe COVID-19, we examine the existing literature summarizing the characteristics of MDSCs, provide evidence of MDSCs in facilitating severe COVID-19 pathogenesis, and discuss the potential therapeutic avenues that can be explored to reduce the risk and burden of severe COVID-19. We also provide a web app where users can visualize the temporal changes in specific genes or MDSC-related gene sets during severe COVID-19 progression and disease resolution, based on our previous study.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Len</LastName><ForeName>Jia Soon</ForeName><Initials>JS</Initials><Identifier Source="ORCID">0000-0002-3436-6399</Identifier><AffiliationInfo><Affiliation>School of Biological Sciences, Nanyang Technological University, Singapore 637551, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koh</LastName><ForeName>Clara W T</ForeName><Initials>CWT</Initials><Identifier Source="ORCID">0000-0003-1413-6032</Identifier><AffiliationInfo><Affiliation>Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore 169857, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Kuan Rong</ForeName><Initials>KR</Initials><Identifier Source="ORCID">0000-0002-2427-671X</Identifier><AffiliationInfo><Affiliation>Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore 169857, Singapore.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MOH-000610-00</GrantID><Agency>National Medical Research Council</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072737" MajorTopicYN="Y">Myeloid-Derived Suppressor Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020869" MajorTopicYN="N">Gene Expression Profiling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016867" MajorTopicYN="N">Immunocompromised Host</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">T cells</Keyword><Keyword MajorTopicYN="N">infection</Keyword><Keyword MajorTopicYN="N">innate immunity</Keyword><Keyword MajorTopicYN="N">myeloid-derived suppressor cells</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>12</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>24</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>23</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>23</Day><Hour>1</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38257728</ArticleId><ArticleId IdType="pmc">PMC10821470</ArticleId><ArticleId IdType="doi">10.3390/v16010027</ArticleId><ArticleId IdType="pii">v16010027</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Johns Hopkins University COVID-19 Map&#x2014;Johns Hopkins Coronavirus Resource Center.  [(accessed on 6 October 2023)].  Available online:  https://coronavirus.jhu.edu/map.html.</Citation></Reference><Reference><Citation>Li G., Hilgenfeld R., Whitley R., De Clercq E. Therapeutic Strategies for COVID-19: Progress and Lessons Learned. Nat. Rev. Drug Discov. 2023;22:449&#x2013;475. doi: 10.1038/s41573-023-00672-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41573-023-00672-y</ArticleId><ArticleId IdType="pmc">PMC10113999</ArticleId><ArticleId IdType="pubmed">37076602</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson C.B., Farzan M., Chen B., Choe H. Mechanisms of SARS-CoV-2 Entry into Cells. Nat. Rev. Mol. Cell Biol. 2022;23:3&#x2013;20. doi: 10.1038/s41580-021-00418-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-021-00418-x</ArticleId><ArticleId IdType="pmc">PMC8491763</ArticleId><ArticleId IdType="pubmed">34611326</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J., Petitjean S.J.L., Koehler M., Zhang Q., Dumitru A.C., Chen W., Derclaye S., Vincent S.P., Soumillion P., Alsteens D. Molecular Interaction and Inhibition of SARS-CoV-2 Binding to the ACE2 Receptor. Nat. Commun. 2020;11:4541. doi: 10.1038/s41467-020-18319-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-18319-6</ArticleId><ArticleId IdType="pmc">PMC7486399</ArticleId><ArticleId IdType="pubmed">32917884</ArticleId></ArticleIdList></Reference><Reference><Citation>Benton D.J., Wrobel A.G., Xu P., Roustan C., Martin S.R., Rosenthal P.B., Skehel J.J., Gamblin S.J. Receptor Binding and Priming of the Spike Protein of SARS-CoV-2 for Membrane Fusion. Nature. 2020;588:327&#x2013;330. doi: 10.1038/s41586-020-2772-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2772-0</ArticleId><ArticleId IdType="pmc">PMC7116727</ArticleId><ArticleId IdType="pubmed">32942285</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L., Wang Z. Bench-to-Bedside: Innovation of Small Molecule Anti-SARS-CoV-2 Drugs in China. Eur. J. Med. Chem. 2023;257:115503. doi: 10.1016/j.ejmech.2023.115503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2023.115503</ArticleId><ArticleId IdType="pmc">PMC10193775</ArticleId><ArticleId IdType="pubmed">37229831</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B., Guo H., Zhou P., Shi Z.-L. Characteristics of SARS-CoV-2 and COVID-19. Nat. Rev. Microbiol. 2021;19:141&#x2013;154. doi: 10.1038/s41579-020-00459-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-020-00459-7</ArticleId><ArticleId IdType="pmc">PMC7537588</ArticleId><ArticleId IdType="pubmed">33024307</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioannidis J.P.A. Global Perspective of COVID-19 Epidemiology for a Full-Cycle Pandemic. Eur. J. Clin. Investig. 2020;50:e13423. doi: 10.1111/eci.13423.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eci.13423</ArticleId><ArticleId IdType="pmc">PMC7646031</ArticleId><ArticleId IdType="pubmed">33026101</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan W.-J., Liang W.-H., Zhao Y., Liang H.-R., Chen Z.-S., Li Y.-M., Liu X.-Q., Chen R.-C., Tang C.-L., Wang T., et al. Comorbidity and Its Impact on 1590 Patients with COVID-19 in China: A Nationwide Analysis. Eur. Respir. J. 2020;55:2000547. doi: 10.1183/13993003.00547-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00547-2020</ArticleId><ArticleId IdType="pmc">PMC7098485</ArticleId><ArticleId IdType="pubmed">32217650</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans R.A., Dube S., Lu Y., Yates M., Arnetorp S., Barnes E., Bell S., Carty L., Evans K., Graham S., et al. Impact of COVID-19 on Immunocompromised Populations during the Omicron Era: Insights from the Observational Population-Based INFORM Study. Lancet Reg. Health&#x2014;Eur. 2023;35:100747. doi: 10.1016/j.lanepe.2023.100747.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2023.100747</ArticleId><ArticleId IdType="pmc">PMC10730312</ArticleId><ArticleId IdType="pubmed">38115964</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Valle D.M., Kim-Schulze S., Huang H.-H., Beckmann N.D., Nirenberg S., Wang B., Lavin Y., Swartz T.H., Madduri D., Stock A., et al. An Inflammatory Cytokine Signature Predicts COVID-19 Severity and Survival. Nat. Med. 2020;26:1636&#x2013;1643. doi: 10.1038/s41591-020-1051-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-1051-9</ArticleId><ArticleId IdType="pmc">PMC7869028</ArticleId><ArticleId IdType="pubmed">32839624</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., et al. Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan, China. Lancet. 2020;395:497&#x2013;506. doi: 10.1016/S0140-6736(20)30183-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray S.M., Ansari A.M., Frater J., Klenerman P., Dunachie S., Barnes E., Ogbe A. The Impact of Pre-Existing Cross-Reactive Immunity on SARS-CoV-2 Infection and Vaccine Responses. Nat. Rev. Immunol. 2023;23:304&#x2013;316. doi: 10.1038/s41577-022-00809-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-022-00809-x</ArticleId><ArticleId IdType="pmc">PMC9765363</ArticleId><ArticleId IdType="pubmed">36539527</ArticleId></ArticleIdList></Reference><Reference><Citation>Peckham H., de Gruijter N.M., Raine C., Radziszewska A., Ciurtin C., Wedderburn L.R., Rosser E.C., Webb K., Deakin C.T. Male Sex Identified by Global COVID-19 Meta-Analysis as a Risk Factor for Death and ITU Admission. Nat. Commun. 2020;11:6317. doi: 10.1038/s41467-020-19741-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19741-6</ArticleId><ArticleId IdType="pmc">PMC7726563</ArticleId><ArticleId IdType="pubmed">33298944</ArticleId></ArticleIdList></Reference><Reference><Citation>Sze S., Pan D., Nevill C.R., Gray L.J., Martin C.A., Nazareth J., Minhas J.S., Divall P., Khunti K., Abrams K.R., et al. Ethnicity and Clinical Outcomes in COVID-19: A Systematic Review and Meta-Analysis. eClinicalMedicine. 2020;29:100630. doi: 10.1016/j.eclinm.2020.100630.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100630</ArticleId><ArticleId IdType="pmc">PMC7658622</ArticleId><ArticleId IdType="pubmed">33200120</ArticleId></ArticleIdList></Reference><Reference><Citation>McGurnaghan S.J., Weir A., Bishop J., Kennedy S., Blackbourn L.A.K., McAllister D.A., Hutchinson S., Caparrotta T.M., Mellor J., Jeyam A., et al. Risks of and Risk Factors for COVID-19 Disease in People with Diabetes: A Cohort Study of the Total Population of Scotland. Lancet Diabetes Endocrinol. 2021;9:82&#x2013;93. doi: 10.1016/S2213-8587(20)30405-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(20)30405-8</ArticleId><ArticleId IdType="pmc">PMC7832778</ArticleId><ArticleId IdType="pubmed">33357491</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan K.R., Koh C.W.T., Ng D.H.L., Qin S., Ooi J.S.G., Ong E.Z., Zhang S.L.X., Sam H., Kalimuddin S., Low J.G.H., et al. Early Peripheral Blood MCEMP1 and HLA-DRA Expression Predicts COVID-19 Prognosis. eBioMedicine. 2023;89:104472. doi: 10.1016/j.ebiom.2023.104472.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2023.104472</ArticleId><ArticleId IdType="pmc">PMC9934388</ArticleId><ArticleId IdType="pubmed">36801619</ArticleId></ArticleIdList></Reference><Reference><Citation>Falck-Jones S., &#xd6;sterberg B., Smed-S&#xf6;rensen A. Respiratory and Systemic Monocytes, Dendritic Cells, and Myeloid-Derived Suppressor Cells in COVID-19: Implications for Disease Severity. J. Intern. Med. 2023;293:130&#x2013;143. doi: 10.1111/joim.13559.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13559</ArticleId><ArticleId IdType="pmc">PMC9538918</ArticleId><ArticleId IdType="pubmed">35996885</ArticleId></ArticleIdList></Reference><Reference><Citation>Sacchi A., Grassi G., Bordoni V., Lorenzini P., Cimini E., Casetti R., Tartaglia E., Marchioni L., Petrosillo N., Palmieri F., et al. Early Expansion of Myeloid-Derived Suppressor Cells Inhibits SARS-CoV-2 Specific T-Cell Response and May Predict Fatal COVID-19 Outcome. Cell Death Dis. 2020;11:921. doi: 10.1038/s41419-020-03125-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-020-03125-1</ArticleId><ArticleId IdType="pmc">PMC7590570</ArticleId><ArticleId IdType="pubmed">33110074</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabrilovich D.I., Bronte V., Chen S.-H., Colombo M.P., Ochoa A., Ostrand-Rosenberg S., Schreiber H. The Terminology Issue for Myeloid-Derived Suppressor Cells. Cancer Res. 2007;67:425. doi: 10.1158/0008-5472.CAN-06-3037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-06-3037</ArticleId><ArticleId IdType="pmc">PMC1941787</ArticleId><ArticleId IdType="pubmed">17210725</ArticleId></ArticleIdList></Reference><Reference><Citation>Veglia F., Sanseviero E., Gabrilovich D.I. Myeloid-Derived Suppressor Cells in the Era of Increasing Myeloid Cell Diversity. Nat. Rev. Immunol. 2021;21:485&#x2013;498. doi: 10.1038/s41577-020-00490-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-00490-y</ArticleId><ArticleId IdType="pmc">PMC7849958</ArticleId><ArticleId IdType="pubmed">33526920</ArticleId></ArticleIdList></Reference><Reference><Citation>Veglia F., Perego M., Gabrilovich D. Myeloid-Derived Suppressor Cells Coming of Age. Nat. Immunol. 2018;19:108&#x2013;119. doi: 10.1038/s41590-017-0022-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-017-0022-x</ArticleId><ArticleId IdType="pmc">PMC5854158</ArticleId><ArticleId IdType="pubmed">29348500</ArticleId></ArticleIdList></Reference><Reference><Citation>Condamine T., Gabrilovich D.I. Molecular Mechanisms Regulating Myeloid-Derived Suppressor Cell Differentiation and Function. Trends Immunol. 2011;32:19&#x2013;25. doi: 10.1016/j.it.2010.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2010.10.002</ArticleId><ArticleId IdType="pmc">PMC3053028</ArticleId><ArticleId IdType="pubmed">21067974</ArticleId></ArticleIdList></Reference><Reference><Citation>Hegde S., Leader A.M., Merad M. MDSC: Markers, Development, States, and Unaddressed Complexity. Immunity. 2021;54:875&#x2013;884. doi: 10.1016/j.immuni.2021.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2021.04.004</ArticleId><ArticleId IdType="pmc">PMC8709560</ArticleId><ArticleId IdType="pubmed">33979585</ArticleId></ArticleIdList></Reference><Reference><Citation>Ushach I., Zlotnik A. Biological Role of Granulocyte Macrophage Colony-Stimulating Factor (GM-CSF) and Macrophage Colony-Stimulating Factor (M-CSF) on Cells of the Myeloid Lineage. J. Leukoc. Biol. 2016;100:481&#x2013;489. doi: 10.1189/jlb.3RU0316-144R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.3RU0316-144R</ArticleId><ArticleId IdType="pmc">PMC4982611</ArticleId><ArticleId IdType="pubmed">27354413</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohl K., Tenbrock K. Reactive Oxygen Species as Regulators of MDSC-Mediated Immune Suppression. Front. Immunol. 2018;9:2499. doi: 10.3389/fimmu.2018.02499.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02499</ArticleId><ArticleId IdType="pmc">PMC6218613</ArticleId><ArticleId IdType="pubmed">30425715</ArticleId></ArticleIdList></Reference><Reference><Citation>Bordoni V., Sacchi A., Cimini E., Notari S., Grassi G., Tartaglia E., Casetti R., Giancola M.L., Bevilacqua N., Maeurer M., et al. An Inflammatory Profile Correlates With Decreased Frequency of Cytotoxic Cells in Coronavirus Disease 2019. Clin. Infect. Dis. 2020;71:2272&#x2013;2275. doi: 10.1093/cid/ciaa577.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa577</ArticleId><ArticleId IdType="pmc">PMC7239202</ArticleId><ArticleId IdType="pubmed">32407466</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg A., Spector S.A. HIV Type 1 Gp120&#x2013;Induced Expansion of Myeloid Derived Suppressor Cells Is Dependent on Interleukin 6 and Suppresses Immunity. J. Infect. Dis. 2014;209:441&#x2013;451. doi: 10.1093/infdis/jit469.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jit469</ArticleId><ArticleId IdType="pmc">PMC3883171</ArticleId><ArticleId IdType="pubmed">23999600</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang F., Yu X., Zhou C., Mao R., Zhu M., Zhu H., Ma Z., Mitra B., Zhao G., Huang Y., et al. Hepatitis B e Antigen Induces the Expansion of Monocytic Myeloid-Derived Suppressor Cells to Dampen T-Cell Function in Chronic Hepatitis B Virus Infection. PLoS Pathog. 2019;15:e1007690. doi: 10.1371/journal.ppat.1007690.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1007690</ArticleId><ArticleId IdType="pmc">PMC6472891</ArticleId><ArticleId IdType="pubmed">30998767</ArticleId></ArticleIdList></Reference><Reference><Citation>Tcyganov E.N., Hanabuchi S., Hashimoto A., Campbell D., Kar G., Slidel T.W.F., Cayatte C., Landry A., Pilataxi F., Hayes S., et al. Distinct Mechanisms Govern Populations of Myeloid-Derived Suppressor Cells in Chronic Viral Infection and Cancer. J. Clin. Investig. 2021;131:e145971. doi: 10.1172/JCI145971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI145971</ArticleId><ArticleId IdType="pmc">PMC8363287</ArticleId><ArticleId IdType="pubmed">34228641</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabrilovich D.I. Myeloid-Derived Suppressor Cells. Cancer Immunol. Res. 2017;5:3&#x2013;8. doi: 10.1158/2326-6066.CIR-16-0297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/2326-6066.CIR-16-0297</ArticleId><ArticleId IdType="pmc">PMC5426480</ArticleId><ArticleId IdType="pubmed">28052991</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostrand-Rosenberg S., Lamb T.J., Pawelec G. Here, There, and Everywhere: Myeloid-Derived Suppressor Cells in Immunology. J. Immunol. 2023;210:1183&#x2013;1197. doi: 10.4049/jimmunol.2200914.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.2200914</ArticleId><ArticleId IdType="pmc">PMC10111205</ArticleId><ArticleId IdType="pubmed">37068300</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballbach M., Dannert A., Singh A., Siegmund D.M., Handgretinger R., Piali L., Rieber N., Hartl D. Expression of Checkpoint Molecules on Myeloid-Derived Suppressor Cells. Immunol. Lett. 2017;192:1&#x2013;6. doi: 10.1016/j.imlet.2017.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imlet.2017.10.001</ArticleId><ArticleId IdType="pubmed">28987474</ArticleId></ArticleIdList></Reference><Reference><Citation>Dean M.J., Ochoa J.B., Sanchez-Pino M.D., Zabaleta J., Garai J., Del Valle L., Wyczechowska D., Baiamonte L.B., Philbrook P., Majumder R., et al. Severe COVID-19 Is Characterized by an Impaired Type I Interferon Response and Elevated Levels of Arginase Producing Granulocytic Myeloid Derived Suppressor Cells. Front. Immunol. 2021;12:695972. doi: 10.3389/fimmu.2021.695972.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.695972</ArticleId><ArticleId IdType="pmc">PMC8324422</ArticleId><ArticleId IdType="pubmed">34341659</ArticleId></ArticleIdList></Reference><Reference><Citation>Srivastava M.K., Sinha P., Clements V.K., Rodriguez P., Ostrand-Rosenberg S. Myeloid-Derived Suppressor Cells Inhibit T-Cell Activation by Depleting Cystine and Cysteine. Cancer Res. 2010;70:68&#x2013;77. doi: 10.1158/0008-5472.CAN-09-2587.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-09-2587</ArticleId><ArticleId IdType="pmc">PMC2805057</ArticleId><ArticleId IdType="pubmed">20028852</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagaraj S., Gupta K., Pisarev V., Kinarsky L., Sherman S., Kang L., Herber D.L., Schneck J., Gabrilovich D.I. Altered Recognition of Antigen Is a Mechanism of CD8+ T Cell Tolerance in Cancer. Nat. Med. 2007;13:828&#x2013;835. doi: 10.1038/nm1609.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1609</ArticleId><ArticleId IdType="pmc">PMC2135607</ArticleId><ArticleId IdType="pubmed">17603493</ArticleId></ArticleIdList></Reference><Reference><Citation>Bronte V., Brandau S., Chen S.-H., Colombo M.P., Frey A.B., Greten T.F., Mandruzzato S., Murray P.J., Ochoa A., Ostrand-Rosenberg S., et al. Recommendations for Myeloid-Derived Suppressor Cell Nomenclature and Characterization Standards. Nat. Commun. 2016;7:12150. doi: 10.1038/ncomms12150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms12150</ArticleId><ArticleId IdType="pmc">PMC4935811</ArticleId><ArticleId IdType="pubmed">27381735</ArticleId></ArticleIdList></Reference><Reference><Citation>Aarts C.E.M., Hiemstra I.H., B&#xe9;guin E.P., Hoogendijk A.J., Bouchmal S., van Houdt M., Tool A.T.J., Mul E., Jansen M.H., Janssen H., et al. Activated Neutrophils Exert Myeloid-Derived Suppressor Cell Activity Damaging T Cells beyond Repair. Blood Adv. 2019;3:3562&#x2013;3574. doi: 10.1182/bloodadvances.2019031609.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2019031609</ArticleId><ArticleId IdType="pmc">PMC6880908</ArticleId><ArticleId IdType="pubmed">31738831</ArticleId></ArticleIdList></Reference><Reference><Citation>Pillay J., Tak T., Kamp V.M., Koenderman L. Immune Suppression by Neutrophils and Granulocytic Myeloid-Derived Suppressor Cells: Similarities and Differences. Cell. Mol. Life Sci. 2013;70:3813&#x2013;3827. doi: 10.1007/s00018-013-1286-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-013-1286-4</ArticleId><ArticleId IdType="pmc">PMC3781313</ArticleId><ArticleId IdType="pubmed">23423530</ArticleId></ArticleIdList></Reference><Reference><Citation>Nefedova Y., Nagaraj S., Rosenbauer A., Muro-Cacho C., Sebti S.M., Gabrilovich D.I. Regulation of Dendritic Cell Differentiation and Antitumor Immune Response in Cancer by Pharmacologic-Selective Inhibition of the Janus-Activated Kinase 2/Signal Transducers and Activators of Transcription 3 Pathway. Cancer Res. 2005;65:9525&#x2013;9535. doi: 10.1158/0008-5472.CAN-05-0529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-05-0529</ArticleId><ArticleId IdType="pmc">PMC1351362</ArticleId><ArticleId IdType="pubmed">16230418</ArticleId></ArticleIdList></Reference><Reference><Citation>Li K., Shi H., Zhang B., Ou X., Ma Q., Chen Y., Shu P., Li D., Wang Y. Myeloid-Derived Suppressor Cells as Immunosuppressive Regulators and Therapeutic Targets in Cancer. Signal Transduct. Target. Ther. 2021;6:362. doi: 10.1038/s41392-021-00670-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00670-9</ArticleId><ArticleId IdType="pmc">PMC8497485</ArticleId><ArticleId IdType="pubmed">34620838</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabrilovich D.I., Nagaraj S. Myeloid-Derived Suppressor Cells as Regulators of the Immune System. Nat. Rev. Immunol. 2009;9:162&#x2013;174. doi: 10.1038/nri2506.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2506</ArticleId><ArticleId IdType="pmc">PMC2828349</ArticleId><ArticleId IdType="pubmed">19197294</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong E.Z., Kalimuddin S., Chia W.C., Ooi S.H., Koh C.W., Tan H.C., Zhang S.L., Low J.G., Ooi E.E., Chan K.R. Temporal Dynamics of the Host Molecular Responses Underlying Severe COVID-19 Progression and Disease Resolution. eBioMedicine. 2021;65:103262. doi: 10.1016/j.ebiom.2021.103262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103262</ArticleId><ArticleId IdType="pmc">PMC7937043</ArticleId><ArticleId IdType="pubmed">33691247</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyes M., Filbin M.R., Bhattacharyya R.P., Sonny A., Mehta A., Billman K., Kays K.R., Pinilla-Vera M., Benson M.E., Cosimi L.A., et al. Plasma from Patients with Bacterial Sepsis or Severe COVID-19 Induces Suppressive Myeloid Cell Production from Hematopoietic Progenitors in Vitro. Sci. Transl. Med. 2021;13:eabe9599. doi: 10.1126/scitranslmed.abe9599.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abe9599</ArticleId><ArticleId IdType="pmc">PMC8432955</ArticleId><ArticleId IdType="pubmed">34103408</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilk A.J., Lee M.J., Wei B., Parks B., Pi R., Mart&#xed;nez-Col&#xf3;n G.J., Ranganath T., Zhao N.Q., Taylor S., Becker W., et al. Multi-Omic Profiling Reveals Widespread Dysregulation of Innate Immunity and Hematopoiesis in COVID-19. J. Exp. Med. 2021;218:e20210582. doi: 10.1084/jem.20210582.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20210582</ArticleId><ArticleId IdType="pmc">PMC8210586</ArticleId><ArticleId IdType="pubmed">34128959</ArticleId></ArticleIdList></Reference><Reference><Citation>Kvedaraite E., Hertwig L., Sinha I., Ponzetta A., Hed Myrberg I., Lourda M., Dzidic M., Akber M., Klingstr&#xf6;m J., Folkesson E., et al. Major Alterations in the Mononuclear Phagocyte Landscape Associated with COVID-19 Severity. Proc. Natl. Acad. Sci. USA. 2021;118:e2018587118. doi: 10.1073/pnas.2018587118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2018587118</ArticleId><ArticleId IdType="pmc">PMC8017719</ArticleId><ArticleId IdType="pubmed">33479167</ArticleId></ArticleIdList></Reference><Reference><Citation>Shivram H., Hackney J.A., Rosenberger C.M., Teterina A., Qamra A., Onabajo O., McBride J., Cai F., Bao M., Tsai L., et al. Transcriptomic and Proteomic Assessment of Tocilizumab Response in a Randomized Controlled Trial of Patients Hospitalized with COVID-19. iScience. 2023;26:107597. doi: 10.1016/j.isci.2023.107597.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2023.107597</ArticleId><ArticleId IdType="pmc">PMC10470387</ArticleId><ArticleId IdType="pubmed">37664617</ArticleId></ArticleIdList></Reference><Reference><Citation>LaSalle T.J., Gonye A.L.K., Freeman S.S., Kaplonek P., Gushterova I., Kays K.R., Manakongtreecheep K., Tantivit J., Rojas-Lopez M., Russo B.C., et al. Longitudinal Characterization of Circulating Neutrophils Uncovers Phenotypes Associated with Severity in Hospitalized COVID-19 Patients. Cell Rep. Med. 2022;3:100779. doi: 10.1016/j.xcrm.2022.100779.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2022.100779</ArticleId><ArticleId IdType="pmc">PMC9510054</ArticleId><ArticleId IdType="pubmed">36208629</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Wen Y., Xie X., Liu Y., Tan X., Cai Q., Zhang Y., Cheng L., Xu G., Zhang S., et al. Dysregulated Hematopoiesis in Bone Marrow Marks Severe COVID-19. Cell Discov. 2021;7:60. doi: 10.1038/s41421-021-00296-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41421-021-00296-9</ArticleId><ArticleId IdType="pmc">PMC8335717</ArticleId><ArticleId IdType="pubmed">34349096</ArticleId></ArticleIdList></Reference><Reference><Citation>Takano T., Matsumura T., Adachi Y., Terahara K., Moriyama S., Onodera T., Nishiyama A., Kawana-Tachikawa A., Miki S., Hosoya-Nakayama K., et al. Myeloid Cell Dynamics Correlating with Clinical Outcomes of Severe COVID-19 in Japan. Int. Immunol. 2021;33:241&#x2013;247. doi: 10.1093/intimm/dxab005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intimm/dxab005</ArticleId><ArticleId IdType="pmc">PMC7928855</ArticleId><ArticleId IdType="pubmed">33538817</ArticleId></ArticleIdList></Reference><Reference><Citation>Silvin A., Chapuis N., Dunsmore G., Goubet A.-G., Dubuisson A., Derosa L., Almire C., H&#xe9;non C., Kosmider O., Droin N., et al. Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19. Cell. 2020;182:1401&#x2013;1418.e18. doi: 10.1016/j.cell.2020.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.08.002</ArticleId><ArticleId IdType="pmc">PMC7405878</ArticleId><ArticleId IdType="pubmed">32810439</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulte-Schrepping J., Reusch N., Paclik D., Ba&#xdf;ler K., Schlickeiser S., Zhang B., Kr&#xe4;mer B., Krammer T., Brumhard S., Bonaguro L., et al. Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment. Cell. 2020;182:1419&#x2013;1440.e23. doi: 10.1016/j.cell.2020.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.08.001</ArticleId><ArticleId IdType="pmc">PMC7405822</ArticleId><ArticleId IdType="pubmed">32810438</ArticleId></ArticleIdList></Reference><Reference><Citation>Agrati C., Sacchi A., Bordoni V., Cimini E., Notari S., Grassi G., Casetti R., Tartaglia E., Lalle E., D&#x2019;Abramo A., et al. Expansion of Myeloid-Derived Suppressor Cells in Patients with Severe Coronavirus Disease (COVID-19) Cell Death Differ. 2020;27:3196&#x2013;3207. doi: 10.1038/s41418-020-0572-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-020-0572-6</ArticleId><ArticleId IdType="pmc">PMC7278239</ArticleId><ArticleId IdType="pubmed">32514047</ArticleId></ArticleIdList></Reference><Reference><Citation>Falck-Jones S., Vangeti S., Yu M., Falck-Jones R., Cagigi A., Badolati I., &#xd6;sterberg B., Lautenbach M.J., &#xc5;hlberg E., Lin A., et al. Functional Monocytic Myeloid-Derived Suppressor Cells Increase in Blood but Not Airways and Predict COVID-19 Severity. J. Clin. Investig. 2021;131:e144734. doi: 10.1172/JCI144734.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI144734</ArticleId><ArticleId IdType="pmc">PMC7954608</ArticleId><ArticleId IdType="pubmed">33492309</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson E.A., Cascino K., Ordonez A.A., Zhou W., Vaghasia A., Hamacher-Brady A., Brady N.R., Sun I.-H., Wang R., Rosenberg A.Z., et al. Metabolic Programs Define Dysfunctional Immune Responses in Severe COVID-19 Patients. Cell Rep. 2021;34:108863. doi: 10.1016/j.celrep.2021.108863.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.108863</ArticleId><ArticleId IdType="pmc">PMC7908880</ArticleId><ArticleId IdType="pubmed">33691089</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue G., Jiang M., Zhao R., Le A., Li J. Elevated Frequencies of CD14+HLA-DRlo/neg MDSCs in COVID-19 Patients. Aging. 2021;13:6236&#x2013;6246. doi: 10.18632/aging.202571.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.202571</ArticleId><ArticleId IdType="pmc">PMC7993675</ArticleId><ArticleId IdType="pubmed">33640878</ArticleId></ArticleIdList></Reference><Reference><Citation>Marais C., Claude C., Semaan N., Charbel R., Barreault S., Travert B., Piloquet J.-E., Demailly Z., Morin L., Merchaoui Z., et al. Myeloid Phenotypes in Severe COVID-19 Predict Secondary Infection and Mortality: A Pilot Study. Ann. Intensive Care. 2021;11:111. doi: 10.1186/s13613-021-00896-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-021-00896-4</ArticleId><ArticleId IdType="pmc">PMC8278374</ArticleId><ArticleId IdType="pubmed">34259942</ArticleId></ArticleIdList></Reference><Reference><Citation>Jim&#xe9;nez-Cortegana C., S&#xe1;nchez-Jim&#xe9;nez F., P&#xe9;rez-P&#xe9;rez A., &#xc1;lvarez N., Sousa A., Cant&#xf3;n-Bulnes L., Vilari&#xf1;o-Garc&#xed;a T., Fuentes S., Mart&#xed;n S., Jim&#xe9;nez M., et al. Low Levels of Granulocytic Myeloid-Derived Suppressor Cells May Be a Good Marker of Survival in the Follow-Up of Patients With Severe COVID-19. Front. Immunol. 2022;12:801410. doi: 10.3389/fimmu.2021.801410.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.801410</ArticleId><ArticleId IdType="pmc">PMC8835351</ArticleId><ArticleId IdType="pubmed">35154077</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu G., Qi F., Li H., Yang Q., Wang H., Wang X., Liu X., Zhao J., Liao X., Liu Y., et al. The Differential Immune Responses to COVID-19 in Peripheral and Lung Revealed by Single-Cell RNA Sequencing. Cell Discov. 2020;6:73. doi: 10.1038/s41421-020-00225-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41421-020-00225-2</ArticleId><ArticleId IdType="pmc">PMC7574992</ArticleId><ArticleId IdType="pubmed">33101705</ArticleId></ArticleIdList></Reference><Reference><Citation>Veenith T., Martin H., Le Breuilly M., Whitehouse T., Gao-Smith F., Duggal N., Lord J.M., Mian R., Sarphie D., Moss P. High Generation of Reactive Oxygen Species from Neutrophils in Patients with Severe COVID-19. Sci. Rep. 2022;12:10484. doi: 10.1038/s41598-022-13825-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-13825-7</ArticleId><ArticleId IdType="pmc">PMC9212205</ArticleId><ArticleId IdType="pubmed">35729319</ArticleId></ArticleIdList></Reference><Reference><Citation>Badawy M.A., Yasseen B.A., El-Messiery R.M., Abdel-Rahman E.A., Elkhodiry A.A., Kamel A.G., El-sayed H., Shedra A.M., Hamdy R., Zidan M., et al. Neutrophil-Mediated Oxidative Stress and Albumin Structural Damage Predict COVID-19-Associated Mortality. eLife. 2021;10:e69417. doi: 10.7554/eLife.69417.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.69417</ArticleId><ArticleId IdType="pmc">PMC8641949</ArticleId><ArticleId IdType="pubmed">34821549</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiaee F., Jamaati H., Shahi H., Roofchayee N.D., Varahram M., Folkerts G., Garssen J., Adcock I.M., Mortaz E. Immunophenotype and Function of Circulating Myeloid Derived Suppressor Cells in COVID-19 Patients. Sci. Rep. 2022;12:22570. doi: 10.1038/s41598-022-26943-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-26943-z</ArticleId><ArticleId IdType="pmc">PMC9799710</ArticleId><ArticleId IdType="pubmed">36581679</ArticleId></ArticleIdList></Reference><Reference><Citation>Jim&#xe9;nez-Cortegana C., Lir&#xf3; J., Palaz&#xf3;n-Carri&#xf3;n N., Salamanca E., Sojo-Dorado J., de la Cruz-Merino L., Pascual &#xc1;., Rodr&#xed;guez-Ba&#xf1;o J., S&#xe1;nchez-Margalet V. Increased Blood Monocytic Myeloid Derived Suppressor Cells but Low Regulatory T Lymphocytes in Patients with Mild COVID-19. Viral Immunol. 2021;34:639&#x2013;645. doi: 10.1089/vim.2021.0044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/vim.2021.0044</ArticleId><ArticleId IdType="pubmed">34529510</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan A.T., Linster M., Tan C.W., Le Bert N., Chia W.N., Kunasegaran K., Zhuang Y., Tham C.Y.L., Chia A., Smith G.J.D., et al. Early Induction of Functional SARS-CoV-2-Specific T Cells Associates with Rapid Viral Clearance and Mild Disease in COVID-19 Patients. Cell Rep. 2021;34:108728. doi: 10.1016/j.celrep.2021.108728.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.108728</ArticleId><ArticleId IdType="pmc">PMC7826084</ArticleId><ArticleId IdType="pubmed">33516277</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan S., Shafiei M.S., Longoria C., Schoggins J.W., Savani R.C., Zaki H. SARS-CoV-2 Spike Protein Induces Inflammation via TLR2-Dependent Activation of the NF-&#x3ba;B Pathway. eLife. 2021;10:e68563. doi: 10.7554/eLife.68563.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.68563</ArticleId><ArticleId IdType="pmc">PMC8709575</ArticleId><ArticleId IdType="pubmed">34866574</ArticleId></ArticleIdList></Reference><Reference><Citation>DeDiego M.L., Nieto-Torres J.L., Regla-Nava J.A., Jimenez-Guarde&#xf1;o J.M., Fernandez-Delgado R., Fett C., Casta&#xf1;o-Rodriguez C., Perlman S., Enjuanes L. Inhibition of NF-&#x3ba;B-Mediated Inflammation in Severe Acute Respiratory Syndrome Coronavirus-Infected Mice Increases Survival. J. Virol. 2014;88:913&#x2013;924. doi: 10.1128/JVI.02576-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02576-13</ArticleId><ArticleId IdType="pmc">PMC3911641</ArticleId><ArticleId IdType="pubmed">24198408</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y., Ma L., Cai S., Zhuang Z., Zhao Z., Jin S., Xie W., Zhou L., Zhang L., Zhao J., et al. RNA-Induced Liquid Phase Separation of SARS-CoV-2 Nucleocapsid Protein Facilitates NF-&#x3ba;B Hyper-Activation and Inflammation. Signal Transduct. Target. Ther. 2021;6:167. doi: 10.1038/s41392-021-00575-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00575-7</ArticleId><ArticleId IdType="pmc">PMC8065320</ArticleId><ArticleId IdType="pubmed">33895773</ArticleId></ArticleIdList></Reference><Reference><Citation>Su C.-M., Wang L., Yoo D. Activation of NF-&#x3ba;B and Induction of Proinflammatory Cytokine Expressions Mediated by ORF7a Protein of SARS-CoV-2. Sci. Rep. 2021;11:13464. doi: 10.1038/s41598-021-92941-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-92941-2</ArticleId><ArticleId IdType="pmc">PMC8242070</ArticleId><ArticleId IdType="pubmed">34188167</ArticleId></ArticleIdList></Reference><Reference><Citation>Nilsson-Payant B.E., Uhl S., Grimont A., Doane A.S., Cohen P., Patel R.S., Higgins C.A., Acklin J.A., Bram Y., Chandar V., et al. The NF-&#x3ba;B Transcriptional Footprint Is Essential for SARS-CoV-2 Replication. J. Virol. 2021;95:e0125721. doi: 10.1128/JVI.01257-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01257-21</ArticleId><ArticleId IdType="pmc">PMC8577386</ArticleId><ArticleId IdType="pubmed">34523966</ArticleId></ArticleIdList></Reference><Reference><Citation>Robles J.P., Zamora M., Adan-Castro E., Siqueiros-Marquez L., Martinez de la Escalera G., Clapp C. The Spike Protein of SARS-CoV-2 Induces Endothelial Inflammation through Integrin A5&#x3b2;1 and NF-&#x3ba;B Signaling. J. Biol. Chem. 2022;298:101695. doi: 10.1016/j.jbc.2022.101695.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2022.101695</ArticleId><ArticleId IdType="pmc">PMC8820157</ArticleId><ArticleId IdType="pubmed">35143839</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen G., Wu D., Guo W., Cao Y., Huang D., Wang H., Wang T., Zhang X., Chen H., Yu H., et al. Clinical and Immunological Features of Severe and Moderate Coronavirus Disease 2019. J. Clin. Investig. 2020;130:2620&#x2013;2629. doi: 10.1172/JCI137244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI137244</ArticleId><ArticleId IdType="pmc">PMC7190990</ArticleId><ArticleId IdType="pubmed">32217835</ArticleId></ArticleIdList></Reference><Reference><Citation>Hackney J.A., Shivram H., Vander Heiden J., Overall C., Orozco L., Gao X., Kim E., West N., Qamra A., Chang D., et al. A Myeloid Program Associated with COVID-19 Severity Is Decreased by Therapeutic Blockade of IL-6 Signaling. iScience. 2023;26:107813. doi: 10.1016/j.isci.2023.107813.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2023.107813</ArticleId><ArticleId IdType="pmc">PMC10551843</ArticleId><ArticleId IdType="pubmed">37810211</ArticleId></ArticleIdList></Reference><Reference><Citation>Thwaites R.S., Uruchurtu A.S.S., Siggins M.K., Liew F., Russell C.D., Moore S.C., Fairfield C., Carter E., Abrams S., Short C.-E., et al. Inflammatory Profiles across the Spectrum of Disease Reveal a Distinct Role for GM-CSF in Severe COVID-19. Sci. Immunol. 2021;6:eabg9873. doi: 10.1126/sciimmunol.abg9873.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abg9873</ArticleId><ArticleId IdType="pmc">PMC8128298</ArticleId><ArticleId IdType="pubmed">33692097</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi Y., Ge Y., Wu B., Zhang W., Wu T., Wen T., Liu J., Guo X., Huang C., Jiao Y., et al. Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China. J. Infect. Dis. 2020;222:746&#x2013;754. doi: 10.1093/infdis/jiaa363.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiaa363</ArticleId><ArticleId IdType="pmc">PMC7337752</ArticleId><ArticleId IdType="pubmed">32563194</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabrera L.E., Pekkarinen P.T., Alander M., Nowlan K.H.A., Nguyen N.A., Jokiranta S., Kuivanen S., Patjas A., Mero S., Pakkanen S.H., et al. Characterization of Low-Density Granulocytes in COVID-19. PLoS Pathog. 2021;17:e1009721. doi: 10.1371/journal.ppat.1009721.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1009721</ArticleId><ArticleId IdType="pmc">PMC8284631</ArticleId><ArticleId IdType="pubmed">34228753</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakraborty S., Gonzalez J., Edwards K., Mallajosyula V., Buzzanco A.S., Sherwood R., Buffone C., Kathale N., Providenza S., Xie M.M., et al. Proinflammatory IgG Fc Structures in Patients with Severe COVID-19. Nat. Immunol. 2021;22:67&#x2013;73. doi: 10.1038/s41590-020-00828-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-020-00828-7</ArticleId><ArticleId IdType="pmc">PMC8130642</ArticleId><ArticleId IdType="pubmed">33169014</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoepel W., Chen H.-J., Geyer C.E., Allahverdiyeva S., Manz X.D., de Taeye S.W., Aman J., Mes L., Steenhuis M., Griffith G.R., et al. High Titers and Low Fucosylation of Early Human Anti&#x2013;SARS-CoV-2 IgG Promote Inflammation by Alveolar Macrophages. Sci. Transl. Med. 2021;13:eabf8654. doi: 10.1126/scitranslmed.abf8654.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abf8654</ArticleId><ArticleId IdType="pmc">PMC8158960</ArticleId><ArticleId IdType="pubmed">33979301</ArticleId></ArticleIdList></Reference><Reference><Citation>Wigerblad G., Warner S.A., Ramos-Benitez M.J., Kardava L., Tian X., Miao R., Reger R., Chakraborty M., Wong S., Kanthi Y., et al. Spleen Tyrosine Kinase Inhibition Restores Myeloid Homeostasis in COVID-19. Sci. Adv. 2023;9:eade8272. doi: 10.1126/sciadv.ade8272.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.ade8272</ArticleId><ArticleId IdType="pmc">PMC9812373</ArticleId><ArticleId IdType="pubmed">36598976</ArticleId></ArticleIdList></Reference><Reference><Citation>Schrijver I.T., Th&#xe9;roude C., Antonakos N., Regina J., Le Roy D., Bart P.-A., Chiche J.-D., Perreau M., Pantaleo G., Calandra T., et al. COVID-19 Rapidly Increases MDSCs and Prolongs Innate Immune Dysfunctions. Eur. J. Immunol. 2022;52:1676&#x2013;1679. doi: 10.1002/eji.202249827.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.202249827</ArticleId><ArticleId IdType="pmc">PMC9350042</ArticleId><ArticleId IdType="pubmed">35689332</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheong J.-G., Ravishankar A., Sharma S., Parkhurst C.N., Grassmann S.A., Wingert C.K., Laurent P., Ma S., Paddock L., Miranda I.C., et al. Epigenetic Memory of Coronavirus Infection in Innate Immune Cells and Their Progenitors. Cell. 2023;186:3882&#x2013;3902.e24. doi: 10.1016/j.cell.2023.07.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2023.07.019</ArticleId><ArticleId IdType="pmc">PMC10638861</ArticleId><ArticleId IdType="pubmed">37597510</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopkins F.R., Govender M., Svanberg C., Nordgren J., Waller H., Nilsdotter-Augustinsson &#xc5;., Henningsson A.J., Hagbom M., Sj&#xf6;wall J., Nystr&#xf6;m S., et al. Major Alterations to Monocyte and Dendritic Cell Subsets Lasting More than 6 Months after Hospitalization for COVID-19. Front. Immunol. 2023;13:1082912. doi: 10.3389/fimmu.2022.1082912.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1082912</ArticleId><ArticleId IdType="pmc">PMC9846644</ArticleId><ArticleId IdType="pubmed">36685582</ArticleId></ArticleIdList></Reference><Reference><Citation>Beliakova-Bethell N., Maruthai K., Xu R., Salvador L.C.M., Garg A. Monocytic-Myeloid Derived Suppressor Cells Suppress T-Cell Responses in Recovered SARS CoV2-Infected Individuals. Front. Immunol. 2022;13:894543. doi: 10.3389/fimmu.2022.894543.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.894543</ArticleId><ArticleId IdType="pmc">PMC9263272</ArticleId><ArticleId IdType="pubmed">35812392</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruenjaiman V., Sodsai P., Kueanjinda P., Bunrasmee W., Klinchanhom S., Reantragoon R., Tunvirachaisakul C., Manothummetha K., Mejun N., Liengswangwong K., et al. Impact of SARS-CoV-2 Infection on the Profiles and Responses of Innate Immune Cells after Recovery. J. Microbiol. Immunol. Infect. 2022;55:993&#x2013;1004. doi: 10.1016/j.jmii.2022.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2022.09.001</ArticleId><ArticleId IdType="pmc">PMC9519362</ArticleId><ArticleId IdType="pubmed">36220753</ArticleId></ArticleIdList></Reference><Reference><Citation>Rendeiro A.F., Casano J., Vorkas C.K., Singh H., Morales A., A DeSimone R., Ellsworth G.B., Soave R., Kapadia S.N., Saito K., et al. Profiling of Immune Dysfunction in COVID-19 Patients Allows Early Prediction of Disease Progression. Life Sci. Alliance. 2021;4:e202000955. doi: 10.26508/lsa.202000955.</Citation><ArticleIdList><ArticleId IdType="doi">10.26508/lsa.202000955</ArticleId><ArticleId IdType="pmc">PMC7768198</ArticleId><ArticleId IdType="pubmed">33361110</ArticleId></ArticleIdList></Reference><Reference><Citation>Siemi&#x144;ska I., W&#x119;glarczyk K., Surmiak M., Kurowska-Baran D., Sanak M., Siedlar M., Baran J. Mild and Asymptomatic COVID-19 Convalescents Present Long-Term Endotype of Immunosuppression Associated With Neutrophil Subsets Possessing Regulatory Functions. Front. Immunol. 2021;12:748097. doi: 10.3389/fimmu.2021.748097.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.748097</ArticleId><ArticleId IdType="pmc">PMC8511487</ArticleId><ArticleId IdType="pubmed">34659245</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomi&#x107; S., &#x110;oki&#x107; J., Stevanovi&#x107; D., Ili&#x107; N., Gruden-Movsesijan A., Dini&#x107; M., Radojevi&#x107; D., Beki&#x107; M., Mitrovi&#x107; N., Toma&#x161;evi&#x107; R., et al. Reduced Expression of Autophagy Markers and Expansion of Myeloid-Derived Suppressor Cells Correlate With Poor T Cell Response in Severe COVID-19 Patients. Front. Immunol. 2021;12:614599. doi: 10.3389/fimmu.2021.614599.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.614599</ArticleId><ArticleId IdType="pmc">PMC7937809</ArticleId><ArticleId IdType="pubmed">33692788</ArticleId></ArticleIdList></Reference><Reference><Citation>Taniguchi-Ponciano K., Vadillo E., Mayani H., Gonzalez-Bonilla C.R., Torres J., Majluf A., Flores-Padilla G., Wacher-Rodarte N., Galan J.C., Ferat-Osorio E., et al. Increased Expression of Hypoxia-Induced Factor 1&#x3b1; mRNA and Its Related Genes in Myeloid Blood Cells from Critically Ill COVID-19 Patients. Ann. Med. 2021;53:197&#x2013;207. doi: 10.1080/07853890.2020.1858234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2020.1858234</ArticleId><ArticleId IdType="pmc">PMC7784832</ArticleId><ArticleId IdType="pubmed">33345622</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricke-Hoch M., Stelling E., Lasswitz L., Gunesch A.P., Kasten M., Zapatero-Belinch&#xf3;n F.J., Brogden G., Gerold G., Pietschmann T., Montiel V., et al. Impaired Immune Response Mediated by Prostaglandin E2 Promotes Severe COVID-19 Disease. PLoS ONE. 2021;16:e0255335. doi: 10.1371/journal.pone.0255335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0255335</ArticleId><ArticleId IdType="pmc">PMC8336874</ArticleId><ArticleId IdType="pubmed">34347801</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Y., Sarhan D., Steven A., Seliger B., Kiessling R., Lundqvist A. Inhibition of Tumor-Derived Prostaglandin-E2 Blocks the Induction of Myeloid-Derived Suppressor Cells and Recovers Natural Killer Cell Activity. Clin. Cancer Res. 2014;20:4096&#x2013;4106. doi: 10.1158/1078-0432.CCR-14-0635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1078-0432.CCR-14-0635</ArticleId><ArticleId IdType="pubmed">24907113</ArticleId></ArticleIdList></Reference><Reference><Citation>Altmann D.M., Whettlock E.M., Liu S., Arachchillage D.J., Boyton R.J. The Immunology of Long COVID. Nat. Rev. Immunol. 2023;23:618&#x2013;634. doi: 10.1038/s41577-023-00904-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-023-00904-7</ArticleId><ArticleId IdType="pubmed">37433988</ArticleId></ArticleIdList></Reference><Reference><Citation>Haunhorst S., Bloch W., Javelle F., Kr&#xfc;ger K., Baumgart S., Drube S., Lemh&#xf6;fer C., Reuken P., Stallmach A., M&#xfc;ller M., et al. A Scoping Review of Regulatory T Cell Dynamics in Convalescent COVID-19 Patients&#x2014;Indications for Their Potential Involvement in the Development of Long COVID? Front. Immunol. 2022;13:1070994. doi: 10.3389/fimmu.2022.1070994.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1070994</ArticleId><ArticleId IdType="pmc">PMC9792979</ArticleId><ArticleId IdType="pubmed">36582234</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Yuan D., Chen D.G., Ng R.H., Wang K., Choi J., Li S., Hong S., Zhang R., Xie J., et al. Multiple Early Factors Anticipate Post-Acute COVID-19 Sequelae. Cell. 2022;185:881&#x2013;895.e20. doi: 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S.-J., Nam D., Seong H.C., Hahn Y.S. New Discovery of Myeloid-Derived Suppressor Cell&#x2019;s Tale on Viral Infection and COVID-19. Front. Immunol. 2022;13:842535. doi: 10.3389/fimmu.2022.842535.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.842535</ArticleId><ArticleId IdType="pmc">PMC8850309</ArticleId><ArticleId IdType="pubmed">35185933</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Q., Zhao Y., Li J., Liu J., Yang X., Guo X., Kuang M., Xia H., Zhang Z., Cao L., et al. Induction of Alarmin S100A8/A9 Mediates Activation of Aberrant Neutrophils in the Pathogenesis of COVID-19. Cell Host Microbe. 2021;29:222&#x2013;235.e4. doi: 10.1016/j.chom.2020.12.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.12.016</ArticleId><ArticleId IdType="pmc">PMC7762710</ArticleId><ArticleId IdType="pubmed">33388094</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiorentino G., Coppola A., Izzo R., Annunziata A., Bernardo M., Lombardi A., Trimarco V., Santulli G., Trimarco B. Effects of Adding L-Arginine Orally to Standard Therapy in Patients with COVID-19: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial. Results of the First Interim Analysis. eClinicalMedicine. 2021;40:101125. doi: 10.1016/j.eclinm.2021.101125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101125</ArticleId><ArticleId IdType="pmc">PMC8428476</ArticleId><ArticleId IdType="pubmed">34522871</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>